Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Respir Med. 2022 Jun 7:S2213-2600(22)00180-1. doi: 10.1016/S2213-2600(22)00180-1. Online ahead of print.
Lancet Respir Med. 2022.
PMID: 35688164
Free PMC article.